Review Article| Volume 37, ISSUE 2, P313-325, April 2023

Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia

  • Morgan Pines
    Division of Pediatric Hematology/Oncology, Department of Pediatrics, Weill Cornell Medicine, P-695, 525 East 68th Street, New York, NY 10065, USA

    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, H1117A, New York, NY 10065, USA
    Search for articles by this author
  • Sujit Sheth
    Corresponding author.
    Division of Pediatric Hematology/Oncology, Department of Pediatrics, Weill Cornell Medicine, P-695, 525 East 68th Street, New York, NY 10065, USA
    Search for articles by this author


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Hematology/Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Available at: Accessed September 19, 2022.

      2. Origa R., Beta-thalassemia, In: Adam M.P., Everman D.B., Mirzaa G.M., et al., GeneReviews® [Internet], 2000, University of Washington, Seattle; Seattle (WA). p. 1993–2022. Available at:

        • Ho P.J.
        • Hall G.W.
        • Luo L.Y.
        • et al.
        Beta-thalassaemia intermedia: is it possible consistently to predict phenotype from genotype?.
        Br J Haematol. 1998; 100: 70-78
        • Galanello R.
        • Origa R.
        Orphanet J Rare Dis. 2010; 5: 11
        • Sheth S.
        • Thein S.
        Thalassemia: A Disorder of Globin Synthesis.
        in: Kaushansky K. Prchal J.T. Burns L.J. Williams Hematology. 10 edtion. McGraw Hill, 2021
        • Weatherall D.J.
        Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias.
        Nat Rev Genet. 2001; 2: 245-255
      3. Centers for Disease Control and Prevention, Association of Public Health Laboratories. Hemoglobinopathies: current practices for screening, confirmation and follow-up. 2015. Available at: Accessed November 1, 2022.

        • Fogel B.N.
        • Nguyen H.L.T.
        • Smink G.
        • et al.
        Variability in State-Based Recommendations for Management of Alpha Thalassemia Trait and Silent Carrier Detected on the Newborn Screen.
        J Pediatr. 2018; 195: 283-287
        • Mensah C.
        • Sheth S.
        Optimal strategies for carrier screening and prenatal diagnosis of α- and β-thalassemia.
        Hematol Am Soc Hematol Educ Program. 2021; 2021: 607-613
        • Rappaport V.J.
        • Velazquez M.
        • Williams K.
        Hemoglobinopathies in pregnancy.
        Obstet Gynecol Clin North Am. 2004; 31: 287-vi
        • ACOG Committee on Obstetrics
        ACOG Practice Bulletin No. 78: hemoglobinopathies in pregnancy.
        Obstet Gynecol. 2007; 109: 229-237
        • Bender M.A.
        • Hulihan M.
        • Dorley M.C.
        • et al.
        Newborn Screening Practices for Beta-Thalassemia in the United States.
        Int J Neonatal Screen. 2021; 7: 83
        • Shang X.
        • Xu X.
        Update in the genetics of thalassemia: What clinicians need to know.
        Best Pract Res Clin Obstet Gynaecol. 2017; 39: 3-15
        • Leung T.Y.
        • Lao T.T.
        Thalassaemia in pregnancy.
        Best Pract Res Clin Obstet Gynaecol. 2012; 26: 37-51
        • Hoppe C.C.
        Newborn screening for hemoglobin disorders.
        Hemoglobin. 2011; 35: 556-564
        • Benson J.M.
        • Therrell Jr., B.L.
        History and current status of newborn screening for hemoglobinopathies.
        Semin Perinatol. 2010; 34: 134-144
        • Kohli-Kumar M.
        Screening for anemia in children: AAP recommendations--a critique.
        Pediatrics. 2001; 108: E56
        • Taher A.T.
        • Weatherall D.J.
        • Cappellini M.D.
        Lancet. 2018; 391: 155-167
        • Hoppe C.C.
        Newborn screening for non-sickling hemoglobinopathies.
        Hematol Am Soc Hematol Educ Program. 2009; : 19-25
        • Cao A.
        • Galanello R.
        • Rosatelli M.C.
        Prenatal diagnosis and screening of the haemoglobinopathies.
        Baillieres Clin Haematol. 1998; 11: 215-238
        • Cao A.
        • Kan Y.W.
        The prevention of thalassemia.
        Cold Spring Harb Perspect Med. 2013; 3: a011775
        • Cheung M.C.
        • Goldberg J.D.
        • Kan Y.W.
        Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood.
        Nat Genet. 1996; 14: 264-268
        • Kuliev A.
        • Rechitsky S.
        • Verlinsky O.
        • et al.
        Birth of healthy children after preimplantation diagnosis of thalassemias.
        J Assist Reprod Genet. 1999; 16: 207-211
        • Hung E.C.
        • Chiu R.W.
        • Lo Y.M.
        Detection of circulating fetal nucleic acids: a review of methods and applications.
        J Clin Pathol. 2009; 62: 308-313
        • Viprakasit V.
        • Ekwattanakit S.
        Clinical Classification, Screening and Diagnosis for Thalassemia.
        Hematol Oncol Clin North Am. 2018; 32: 193-211
        • Kattamis C.
        • Metaxotou-Mavromati A.
        • Wood W.G.
        • et al.
        The heterogeneity of normal Hb A2-beta thalassaemia in Greece.
        Br J Haematol. 1979; 42: 109-123
        • Schwartz E.
        The silent carrier of beta thalassemia.
        N Engl J Med. 1969; 281: 1327-1333
        • Rund D.
        • Filon D.
        • Oppenheim A.
        • et al.
        Silent carrier beta-thalassaemia due to a severe beta-globin mutation interacting with other genetic elements.
        Eur J Pediatr. 1993; 152: 574-576
        • Thein S.L.
        Dominant beta thalassaemia: molecular basis and pathophysiology.
        Br J Haematol. 1992; 80: 273-277
        • Hoffmann J.J.
        • Urrechaga E.
        • Aguirre U.
        Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia: a meta-analysis.
        Clin Chem Lab Med. 2015; 53: 1883-1894